5-177386473-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM1
The NM_003052.5(SLC34A1):c.439G>C(p.Val147Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000136 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V147M) has been classified as Uncertain significance.
Frequency
Consequence
NM_003052.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercalcemia, infantile, 2Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
 - dominant hypophosphatemia with nephrolithiasis or osteoporosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - primary Fanconi syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - autosomal recessive infantile hypercalcemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - hypophosphatemic nephrolithiasis/osteoporosis 1Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - Fanconi renotubular syndrome 2Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SLC34A1 | ENST00000324417.6  | c.439G>C | p.Val147Leu | missense_variant | Exon 5 of 13 | 1 | NM_003052.5 | ENSP00000321424.4 | ||
| SLC34A1 | ENST00000512593.5  | c.439G>C | p.Val147Leu | missense_variant | Exon 5 of 9 | 2 | ENSP00000423022.1 | |||
| SLC34A1 | ENST00000507685.5  | n.523G>C | non_coding_transcript_exon_variant | Exon 5 of 10 | 2 | |||||
| SLC34A1 | ENST00000504577.5  | c.*183G>C | downstream_gene_variant | 4 | ENSP00000423733.1 | 
Frequencies
GnomAD3 genomes   AF:  0.0000263  AC: 4AN: 152230Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000199  AC: 5AN: 251438 AF XY:  0.00000736   show subpopulations 
GnomAD4 exome  AF:  0.0000123  AC: 18AN: 1461862Hom.:  0  Cov.: 34 AF XY:  0.0000124  AC XY: 9AN XY: 727238 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000263  AC: 4AN: 152230Hom.:  0  Cov.: 32 AF XY:  0.0000134  AC XY: 1AN XY: 74358 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases    Uncertain:1 
The c.439G>C (p.V147L) alteration is located in exon 5 (coding exon 4) of the SLC34A1 gene. This alteration results from a G to C substitution at nucleotide position 439, causing the valine (V) at amino acid position 147 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided    Uncertain:1 
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with SLC34A1-related conditions. This variant is present in population databases (rs121918611, gnomAD 0.004%). This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 147 of the SLC34A1 protein (p.Val147Leu). -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at